highperformr logo

Occlutech's Overview

Total employees253
HeadquartersHelsingborg
Founded2003

Occlutech is a leading global provider of minimally invasive structural heart disease (SHD) devices. With a mission to improve the quality of life for people born with or developing heart defects, Occlutech develops, manufactures, and commercializes a comprehensive portfolio of occluders, implants, and accessories. The company is dedicated to innovation, research, and clinical excellence, offering solutions for conditions such as Atrial Septal Defects (ASD), Patent Foramen Ovale (PFO), Left Atrial Appendage (LAA) closure, and Ventricular Septal Defects (VSD). Occlutech products are sold in over 90 countries, supported by a strong global presence and a commitment to patient care and advancing medical technology.

Where is Occlutech's Headquarters?

HQ Function

The headquarters serves as the central hub for Occlutech's global operations, encompassing strategic management, research and development leadership, global marketing, finance, and core administrative functions.

Notable Features:

The facility likely incorporates modern office spaces and potentially advanced R&D laboratories, designed to foster innovation and collaboration in medical device development.

Work Culture:

Occlutech fosters a work culture centered on innovation, patient well-being, and scientific excellence. It emphasizes collaboration, ethical practices, and a commitment to developing high-quality, life-saving medical devices.

HQ Significance:

The Helsingborg headquarters is pivotal for driving Occlutech's strategic vision, coordinating its international operations, advancing its product pipeline, and maintaining its position as a leader in structural heart disease solutions.

Values Reflected in HQ: The headquarters environment aims to reflect Occlutech's core values of innovation, quality, integrity, and a profound commitment to improving patient outcomes worldwide.

Location:

Occlutech maintains a significant global footprint, with functions such as research and development, manufacturing, sales, marketing, clinical affairs, and distribution supported internationally. The company's innovative structural heart disease products are available in over 90 countries, facilitated through a network of direct sales teams and dedicated distribution partners, ensuring broad access for patients and healthcare providers worldwide.

Street Address:

Landskronavägen 2

City:

Helsingborg

State/Province:

Skåne

Country:

Sweden

Occlutech's Global Presence

Jena, Thuringia, Germany

Address: Winzerlaer Straße 2, 07745 Jena, Germany

Serves as a critical hub for the production and technological advancement of Occlutech's cardiac devices, primarily supporting the European market and contributing significantly to the company's global supply chain.

Schaumburg, Illinois, USA

Address: 10 N. Martingale Road, Suite 400, Schaumburg, IL 60173, USA

Focuses on expanding Occlutech's market presence in the United States and Canada by providing clinical expertise, product training, and customer support to healthcare professionals utilizing their structural heart devices.

Istanbul, Turkey

Address: Eyüp Sultan Mah. İbni Sina Cad. No:12 Sancaktepe, Istanbul, Turkey

Supports the manufacturing and supply of Occlutech's devices, playing a role in the company's strategy to serve markets in the region and globally.

Buying Intent Signals for Occlutech

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Occlutech

As of April 2025, Occlutech' leadership includes:

Sabine Steiner - Chief Executive Officer (CEO)
Lars Wadman - Chief Financial Officer (CFO)
Stefan Kleidon - Senior Vice President Global Sales & Marketing
Dr. Frank Kubicek - Chief Medical Officer (CMO)
Patrik Björnänger - Senior Vice President Global Operations
Luis Martin - Senior Vice President R&D and Business Development

Investors of Occlutech

Occlutech has been backed by several prominent investors over the years, including:

EQT Private Equity

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

In the past year, Occlutech experienced a key leadership transition with the appointment of a new Chief Executive Officer, Sabine Steiner, poised to guide the company's strategic growth and innovation in the structural heart device sector.

Departures

Tor Peters, Tor Peters departed from his role as CEO of Occlutech.

New Appointments:

Sabine Steiner, Sabine Steiner was appointed as the new Chief Executive Officer of Occlutech.

Technology (Tech Stack) used by Occlutech

Discover the tools Occlutech uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Occlutech Email Formats and Examples

Occlutech generally utilizes standard corporate email formats. The most common patterns are likely 'first.last@occlutech.com' or 'firstinitiallast@occlutech.com'.

first.last@occlutech.com (e.g., jane.doe@occlutech.com) or f[last]@occlutech.com (e.g., jdoe@occlutech.com)

Format

sabine.steiner@occlutech.com

Example

80%

Success rate

News and media

Business WireSeptember 21, 2023

Occlutech Announces First U.S. Patient Enrolled in FROST-PFO Clinical Study

Occlutech announced the enrollment of the first U.S. patient in its FROST-PFO clinical study. The study is designed to evaluate the safety and efficacy of the Occlutech PFO Occluder for recurrent stroke prevention in patients with a PFO. This marks a significant milestone in Occlutech's efforts to bring its innovative PFO closure technology to patients in the United States....more

PR NewswireMarch 2, 2023

Occlutech Appoints Sabine Steiner as New Chief Executive Officer

Occlutech announced the appointment of Sabine Steiner as its new Chief Executive Officer, effective immediately. Ms. Steiner brings over 20 years of extensive experience in the global medical device industry, succeeding Tor Peters. She is expected to lead Occlutech into its next phase of growth and innovation....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Occlutech, are just a search away.